Adhesion Barrier to Represent $769 million Opportunities in Medical Industry

Posted on 2021-11-12 by MarketsandMarkets in Healthcare, Pharmaceuticals // 0 Comments

Illinois, United States, 2021-Nov-12 — /EPR Network/ —

According to the new market research report “Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, Polyethylene Glycol, Fibrin, Collagen & Protein), Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery) – Global Forecast to 2025″, published by MarketsandMarkets™, is valued at an estimated USD 529 million in 2020 and is projected to reach USD 769 million by 2025, at a CAGR of 7.8% during the forecast period.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543

The increasing volume of surgeries and sports-related injuries, rising geriatric population, and the increasing awareness about adhesion formation and adhesion-related diseases are the major factors driving the growth of this market. On the other hand, the reluctance towards the usage of adhesion barriers amongst surgeons is expected to restrain the growth of adhesion barrier market during the forecast period.

However, currently, due to the COVID-19 pandemic, adhesion barrier market is witnessing a slight dip in its growth rate as a result of the decrease in the number of surgical procedures performed to safeguard patients. The dip in surgical interventions is uneven, as different countries were affected by the virus at different points of time in the year. This has resulted in variations in the normal operation of healthcare facilities, such as hospitals and surgical centers. The normalization of the global economy will slowly increase the surgical procedures kept on hold. This will, in turn, lead to a growth in the demand for biosurgery products such as adhesion barrier products from the last quarter of 2020 across North America and Europe, and from the first quarter of 2021 across the rest of the world. The Adhesion Barriers Market is further segmented based on the type, formulation, application, and region.

Browse and in-depth TOC on “Adhesion Barrier Market”

171 – Tables
38 – Figures
203 – Pages

The synthetic adhesion barriers accounted for the largest share of the Adhesion Barrier Market, by type of product, in 2019.

Based on products, the market is further segmented into synthetic and natural adhesion barriers. In 2019, the synthetic adhesion barriers segment accounted for the largest share of the market. Growth in this segment can be attributed to the large number of commercially available synthetic adhesion barriers and their higher utilization as compared to natural adhesion barriers by surgeons in various surgical procedures.

Gel based formulation is the fastest growing segment of the Adhesion Barrier Market, by formulation

Based on the type of formulation, the adhesion barrier market is segmented into film formulations, gel formulations, and liquid formulations. In 2019, film formulations dominated the market owing to the higher adoption of the film form of adhesion barriers by surgeons, coupled with the availability of clinical safety and efficacy data for these formulations.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543

North America will continue to dominate the Adhesion Barriers Market in 2025

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America accounted for the largest share of the market. The large share of the market in North America can primarily be attributed to factors such as the well-developed healthcare system in the region, high public and private healthcare expenditure, growth in the geriatric population, and the increasing incidence of chronic and lifestyle disorders.

The Adhesion Barriers Market is a highly fragmented market with the presence of several multinational and local market players. Some of the prominent players include Baxter International (US), Johnson & Johnson (J&J) (US), Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), and Allosource (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Matched content

Editor’s pick